Allergologie-immunologie - Rhinosinusite chronique avec polypes nasaux : quelle est la place des anticorps monoclonaux en 2020 ? [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?]
Fiche du document
13 janvier 2021
- doi: 10.53738/REVMED.2021.17.720-21.0013
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.720-21.0013
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33443824
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6983B434CAF05
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Rhinosinusitis Paranasal sinuses--InflammationCiter ce document
A. Clottu et al., « Allergologie-immunologie - Rhinosinusite chronique avec polypes nasaux : quelle est la place des anticorps monoclonaux en 2020 ? [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.720-21.0013
Métriques
Partage / Export
Résumé
Chronic rhinosinusitis with nasal polyps is a severe form of chronic rhinosinusitis, which has a strong negative impact on quality of life. Rhinoscopy is helpful for diagnosis, and initial management depends on intra-nasal corticosteroids and sometimes short-term oral corticosteroids (1 to 3 weeks). If well-conducted drug therapy fails, surgery is considered. In the event of post-surgery recurrence or in case of concomitant severe asthma, biologic therapies represent an interesting option. These drugs include dupilumab, mepolizumab, benralizumab and omalizumab. The choice of medication depends on the individual patient context, which includes the presence of atopic dermatitis, eosinophilia, or asthma.